{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:36:26Z","timestamp":1790422586543,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.humpath.2026.106054","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:58:56Z","timestamp":1769101136000},"page":"106054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epstein-Barr virus associated gastric carcinoma: A clinicopathologic study with recognition of a distinctive reticular histologic pattern"],"prefix":"10.1016","volume":"171","author":[{"given":"Julia","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Gumusgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suntrea","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purva","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-2859","authenticated-orcid":false,"given":"Dipti M.","family":"Karamchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.humpath.2026.106054_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.humpath.2026.106054_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.humpath.2026.106054_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11864-015-0331-y","article-title":"Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network","volume":"16","author":"Sunakawa","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.humpath.2026.106054_bib4","series-title":"Digestive system tumours","first-page":"85","article-title":"Gastric adenocarcinoma. In: WHO classification of tumours editorial board","author":"Carneiro","year":"2019"},{"key":"10.1016\/j.humpath.2026.106054_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ctrv.2018.03.006","article-title":"Outlooks on Epstein-Barr virus associated gastric cancer","volume":"66","author":"Naseem","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"7517","key":"10.1016\/j.humpath.2026.106054_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.humpath.2026.106054_bib7","first-page":"469","article-title":"TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics","volume":"33","author":"Zhang","year":"2014","journal-title":"Chin J Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2026.106054_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CJI.0000000000000316","article-title":"Positive status of Epstein-Barr virus as a biomarker for gastric cancer immunotherapy: a prospective observational study","volume":"43","author":"Xie","year":"2020","journal-title":"J Immunother"},{"issue":"3","key":"10.1016\/j.humpath.2026.106054_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/modpathol.2016.202","article-title":"Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1(+) immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications","volume":"30","author":"Saito","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106054_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/gutjnl-2013-304531","article-title":"Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis","volume":"63","author":"Camargo","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.humpath.2026.106054_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1200\/JCO.2004.08.061","article-title":"EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement","volume":"22","author":"van Beek","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106054_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAS.0000000000001018","article-title":"Gastric carcinomas with lymphoid stroma: an evaluation of the histopathologic and molecular features","volume":"42","author":"Hissong","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106054_bib13","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3892\/ijo.2015.2856","article-title":"Update on Epstein-Barr virus and gastric cancer","volume":"46","author":"Shinozaki-Ushiku","year":"2015","journal-title":"Int J Oncol"},{"issue":"26","key":"10.1016\/j.humpath.2026.106054_bib14","first-page":"1214","article-title":"Lymphoepithelioma-like carcinoma of the stomach: a subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein-Barr virus infection","volume":"46","author":"Wang","year":"1999","journal-title":"Hepatogastroenterology"},{"issue":"3\u20134","key":"10.1016\/j.humpath.2026.106054_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000236018","article-title":"Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer","volume":"77","author":"Li","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.humpath.2026.106054_bib16","series-title":"AJCC cancer staging manual","first-page":"203","author":"Ajani","year":"2017"},{"key":"10.1016\/j.humpath.2026.106054_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","article-title":"Epstein-Barr virus-associated gastric cancer: a distinct subtype","volume":"495","author":"Yang","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2026.106054_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102737","article-title":"The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: a systematic review","volume":"127","author":"Bos","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.humpath.2026.106054_bib19","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.humpath.2026.106054_bib20","doi-asserted-by":"crossref","first-page":"32925","DOI":"10.18632\/oncotarget.9076","article-title":"Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers","volume":"7","author":"Derks","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.humpath.2026.106054_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1349-7006.2007.00674.x","article-title":"Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features","volume":"99","author":"Akiba","year":"2008","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.humpath.2026.106054_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1746.2009.05775.x","article-title":"Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis","volume":"24","author":"Lee","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106054_bib23","first-page":"377","article-title":"Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction","volume":"3","author":"Burke","year":"1990","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106054_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4","article-title":"Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations","volume":"38","author":"Watanabe","year":"1976","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.humpath.2026.106054_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.cgh.2015.04.015","article-title":"Features of gastric carcinoma with lymphoid stroma associated with epstein-barr virus","volume":"13","author":"Lim","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106054_bib26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jso.25022","article-title":"Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer","volume":"117","author":"Pereira","year":"2018","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106054_bib27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","article-title":"Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location","volume":"137","author":"Murphy","year":"2009","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.humpath.2026.106054_bib28","first-page":"607","article-title":"A unique morphology of Epstein-Barr virus-related early gastric carcinoma","volume":"3","author":"Uemura","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.humpath.2026.106054_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1440-1827.1997.tb04509.x","article-title":"Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study","volume":"47","author":"Arikawa","year":"1997","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.humpath.2026.106054_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10120-018-0836-8","article-title":"New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression","volume":"22","author":"Gullo","year":"2019","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2026.106054_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12876-021-01683-y","article-title":"Collision of Epstein-Barr virus-positive and -negative gastric cancer, diagnosed by molecular analysis: a case report","volume":"21","author":"Miyabe","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106054_bib32","first-page":"1250","article-title":"Epstein-Barr virus in gastric carcinoma","volume":"143","author":"Tokunaga","year":"1993","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106054_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10120-016-0631-3","article-title":"Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients","volume":"20","author":"Kawazoe","year":"2017","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2026.106054_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12672-022-00479-0","article-title":"PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis","volume":"13","author":"Lima","year":"2022","journal-title":"Discov Oncol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106054_bib35","article-title":"Prognostic implication of EBV infection in gastric Carcinomas: a systematic review and meta-analysis","volume":"59","author":"Pyo","year":"2023","journal-title":"Medicina (Kaunas)"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:10:39Z","timestamp":1776575439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"alternative-id":["S0046817726000237"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106054","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus associated gastric carcinoma: A clinicopathologic study with recognition of a distinctive reticular histologic pattern","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106054"}}